Generic Drugs Antitrust Case
Pharma companies providing pharmaceuticals exclusive to them have vast amounts of control in availability and or pricing. Either can result in increased costs to the patient. Economist Timothy Taylor reviews one particular instance with Teva Pharmaceuticals. Collaboration with other companies to control pricing appears to be Teva’s Director of Strategic Customer Marketing Nisha Patel’s strong […]